Detection of differently expressed genes in human ovarian carcinoma by cDNA Microarray
- VernacularTitle:人卵巢癌组织差异表达基因的cDNA基因芯片检测
- Author:
Xiangdong MA
;
Xiaoming WU
;
Xing MA
;
Biliang CHEN
;
Xiaoyan XIN
;
Detang WANG
- Publication Type:Journal Article
- Keywords:
oligonucleotide array sequence analysis;
gene expression;
ovarian neoplasms
- From:
Medical Journal of Chinese People's Liberation Army
2008;33(1):36-38
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the differently expressed genes in human ovarian carcinoma, and to reveal the molecular mechanism of the cancerous development. Methods The specimens of human ovarian serous adenocarcinoma tissues in stage III, and of normal human ovarian tissues as control were excised during surgery for present study. Clinical stages were determined by the Federation International of Gynecology and Obstetrids (FIGO). Total RNA was isolated from human ovarian tissues, and cDNA probe was labeled and purified. The amount of radioactivity incorporated into the cDNA probes was checked by a scintillation counter. The profiles of gene expression were compared between carcinomas and normal ovarian tissues by cDNA microarray which contained 588 genes totally. Results Forty-four differentially expressed genes were identified from the 588 genes which were from ovarian carcinoma and normal ovarian tissues and compared with cDNA expression array and analyzed by AtlasImage 1.01 software. 11 of the 44 genes were up-regulated in ovarian carcinoma tissues (including c-erbB2, neu, c-fos, c-myc proto-oncogenes, HER2 receptor, and so on), and the other 33 genes were down-regulated (including RAR, MMP18, MMP19, p21, DNA-PK, and so on). Conclusion The gene expressions in human ovarian carcinoma have been detected in present study. It is the differently expressed genes that help us to disclose the potential molecular mechanisms of the developmental process of human ovarian carcinogenesis. The differently expressed genes may provide a useful hallmark for the early diagnosis of human ovarian carcinoma.
